MedTrace Logo

Endocrine Disrupting Chemicals: Potential Effects on Male and Female Reproductive Health in Saskatchewan

NCT02272439 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 118

Last updated 2015-12-21

No results posted yet for this study

Summary

The overall objective of this study is to determine whether serum BPA and/or phthalate concentrations differ in fertile versus infertile men and women in Saskatchewan. The investigators will test the following hypothesis:

1. Serum BPA and/or phthalate concentrations will be greater in women with unexplained infertility or PCOS compared to a control group
2. Serum BPA and/or phthalate concentrations will be greater in men with male factor infertility compared to a control group

Conditions

  • Unexplained Infertility
  • Polycystic Ovarian Syndrome
  • Male Infertility

Sponsors & Collaborators

  • Royal University Hospital Foundation

    collaborator OTHER

  • University of Saskatchewan

    lead OTHER

Principal Investigators

  • Angela Baerwald, PhD · Assistant Professor

Eligibility

Min Age
18 Years
Max Age
43 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-09-30
Completion
2015-01-31

Countries

  • Canada

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02272439 on ClinicalTrials.gov